Hypertension, Anemia Contribute to Racial Disparities in Severe Maternal Morbidity
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Sept. 8, 2023 -- Hypertension and anemia contribute to racial disparities in severe maternal morbidity (SMM), according to two studies published online Sept. 7 in Obstetrics & Gynecology.
Stephanie A. Leonard, Ph.D., from Stanford University in California, and colleagues conducted a population-based study to examine the associations between chronic hypertension and several obstetric and neonatal outcomes. Data were included from 7,955,713 pregnancies, of which 2.1 percent were complicated by chronic hypertension. The researchers found that chronic hypertension was associated with adverse obstetric and neonatal outcomes, with the largest population attributable risks (PARs) seen for preeclampsia with severe features or eclampsia, acute renal failure, and pulmonary edema (22.4, 13.6, and 10.7, respectively). The adjusted PAR percentages for SMM were 5.0, 3.7, 9.0, 3.9, 11.6, 3.2, and 5.5 for American Indian-Alaska Native, Asian, Black, Latino, Native Hawaiian-Pacific Islander, White, and Multiracial-Other, respectively.
Irogue Igbinosa, M.D., from Stanford University in California, and colleagues examined the contribution of antepartum anemia to SMM using data from 3,863,594 births in California from 2011 through 2020. The researchers found that the incidence of antepartum anemia was highest among Black patients followed by Pacific Islander patients (21.5 and 18.2, respectively); incidence was lowest for White pregnant patients (9.6 percent). The PAR percentage for antepartum anemia and SMM was highest for multiracial, Black, and Hispanic patients within each racial and ethnic group (21.4, 20.9, and 20.9 percent, respectively).
"The more evidence we use to standardize our approach to prenatal care, the more we can address and dismantle the effects of implicit bias on health care delivery," Igbinosa said in a statement.
One author from the Leonard study disclosed payment as an expert witness; one author from the Igbinosa study disclosed ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
HTN, Albuminuria Risks No Worse for Kidney Donors Versus Nondonors
THURSDAY, May 30, 2024 -- Living kidney donors and nondonors have similar risks for hypertension and albuminuria, according to a study published online May 23 in the Journal of...
American College of Obstetricians and Gynecologists, May 17-19
The annual meeting of the American College of Obstetricians and Gynecologists was held from May 17 to 19 in San Francisco and was attended by more than 4,000 clinicians...
Antihypertensives Linked to Eczematous Dermatitis in Seniors
FRIDAY, May 24, 2024 -- Antihypertensive drugs are associated with an increased risk for eczematous dermatitis in older adults, and the effect sizes are largest for diuretics and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.